MetLife Deferred Income increased by 0.4% to $5.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $4.73B to $5.18B. Over 4 years (FY 2021 to FY 2025), Deferred Income shows an upward trend with a 9.2% CAGR.
other_deferred_income| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.63B | $3.79B | $3.84B | $3.89B | $4.11B | $4.25B | $4.44B | $4.56B | $4.54B | $4.61B | $4.61B | $4.71B | $4.64B | $4.73B | $4.95B | $5.08B | $5.16B | $5.18B |
| QoQ Change | — | +4.7% | +1.1% | +1.4% | +5.5% | +3.5% | +4.4% | +2.7% | -0.5% | +1.7% | +0.0% | +2.1% | -1.7% | +2.1% | +4.5% | +2.6% | +1.7% | +0.4% |
| YoY Change | — | — | — | — | +13.3% | +12.0% | +15.7% | +17.2% | +10.5% | +8.5% | +3.9% | +3.3% | +2.2% | +2.6% | +7.2% | +7.7% | +11.4% | +9.5% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Asia | $2.98B | $3.10B | $3.08B | $3.13B | $3.23B | $3.31B | $3.35B | $3.37B |
| Latin America | $930.00M | $888.00M | $841.00M | $864.00M | $935.00M | $963.00M | $997.00M | $996.00M |
| EMEA | $612.00M | $632.00M | $622.00M | $647.00M | $683.00M | $709.00M | $723.00M | $717.00M |
| Corporate And Other | — | — | $69.00M | $70.00M | — | — | $73.00M | $75.00M |
| RIS | $29.00M | $28.00M | $27.00M | $26.00M | $25.00M | $24.00M | $23.00M | $22.00M |
| Group Benefits | — | — | $0.00 | — | — | — | $0.00 | — |
| MIM | — | — | — | — | — | — | $0.00 | — |
| Total | $4.61B | $4.71B | $4.64B | $4.73B | $4.95B | $5.08B | $5.16B | $5.18B |
U.S. was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.